155 related articles for article (PubMed ID: 36842474)
1. Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib.
Pestana M; Brito Caldeira M; Duarte B
Actas Dermosifiliogr; 2024 Feb; 115(2):200-201. PubMed ID: 36842474
[No Abstract] [Full Text] [Related]
2. Atopic dermatitis and multilocular alopecia areata simultaneously treated with baricitinib.
Pestana M; Brito Caldeira M; Duarte B
Actas Dermosifiliogr; 2024 Feb; 115(2):T200-T201. PubMed ID: 37952837
[No Abstract] [Full Text] [Related]
3. Baricitinib improved alopecia areata concomitant with atopic dermatitis: A case report.
Uchida H; Kamata M; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2021 Sep; 48(9):e472-e473. PubMed ID: 34151450
[No Abstract] [Full Text] [Related]
4. Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children.
Fang H; Zhang F; Lin W; Jiang Y; Liu Q; Yang D
Front Immunol; 2024; 15():1395288. PubMed ID: 38903518
[TBL] [Abstract][Full Text] [Related]
5. Alopecia areata treatment with baricitinib: different relapse phenotypes.
Dall'Oglio F; Nasca MR; Lacarrubba F; Vitale P; Micali G
J Dermatolog Treat; 2024 Dec; 35(1):2324832. PubMed ID: 38465657
[No Abstract] [Full Text] [Related]
6. Baricitinib for the treatment of alopecia areata in adults: Real-world analysis of 36 patients.
Moreno-Vílchez C; Bonfill-Ortí M; Bauer-Alonso A; Notario J; Figueras-Nart I
J Am Acad Dermatol; 2024 May; 90(5):1059-1061. PubMed ID: 38246562
[No Abstract] [Full Text] [Related]
7. Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib.
De la Torre-Gomar FJ; Velasco-Amador JP; Prados-Carmona Á; Ruiz-Villaverde R
J Dermatolog Treat; 2024 Dec; 35(1):2304630. PubMed ID: 38240097
[No Abstract] [Full Text] [Related]
8. Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata.
Chen D; Huang W; Zhongjie W; Feifeng R; Luo L; Jun Z; Dongmei H; Tian M; Tang L
Rheumatology (Oxford); 2022 Aug; 61(8):e221-e223. PubMed ID: 35148369
[No Abstract] [Full Text] [Related]
9. Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients.
Numata T; Irisawa R; Mori M; Uchiyama M; Harada K
Acta Derm Venereol; 2024 Jan; 104():adv18348. PubMed ID: 38248913
[No Abstract] [Full Text] [Related]
10. Baricitinib in Alopecia Areata.
Messenger A; Harries M
N Engl J Med; 2022 May; 386(18):1751-1752. PubMed ID: 35507486
[No Abstract] [Full Text] [Related]
11. Oral Baricitinib Restores Hair Loss in Alopecia Areata.
Slomski A
JAMA; 2022 Jun; 327(24):2386. PubMed ID: 35762995
[No Abstract] [Full Text] [Related]
12. Refractory cutaneous lichen amyloidosis coexisting with atopic dermatitis responds to the Janus Kinase inhibitor baricitinib.
Xia D; Xiao Y; Li M; Li W
Dermatol Ther; 2022 Sep; 35(9):e15724. PubMed ID: 35855568
[No Abstract] [Full Text] [Related]
13. Possible suppressive effects of baricitinib on serum IL-22 levels in atopic dermatitis.
Uchiyama A; Fujiwara C; Inoue Y; Ishikawa M; Motegi SI
J Dermatol Sci; 2022 Jun; 106(3):189-192. PubMed ID: 35459598
[No Abstract] [Full Text] [Related]
14. Effect of baricitinib in patients with alopecia areata: Usefulness of trichoscopic evaluation.
Diluvio L; Matteini E; Lambiase S; Cioni A; Gaeta Shumak R; Dattola A; Bianchi L; Campione E
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e478-e480. PubMed ID: 38084867
[No Abstract] [Full Text] [Related]
15. Improvement in symptoms of anxiety and depression in patients with atopic dermatitis after treatment with baricitinib.
Thyssen JP; Lio P; Ball S; Pierce E; Sun L; Chen Y; Tan JKL; Augustin M
J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e147-e150. PubMed ID: 34553429
[No Abstract] [Full Text] [Related]
16. The effect of baricitinib add-on therapy in atopic dermatitis patients treated with dupilumab.
Kook HD; Hong N; Lee DH; Jung HJ; Park MY; Ahn J
Dermatol Ther; 2022 Jul; 35(7):e15525. PubMed ID: 35441774
[No Abstract] [Full Text] [Related]
17. Baricitinib (Olumiant) for severe alopecia areata.
Med Lett Drugs Ther; 2022 Sep; 64(1658):139-141. PubMed ID: 36094552
[No Abstract] [Full Text] [Related]
18. Dupilumab-induced enthesoarthritis and refractory atopic dermatitis successfully treated with baricitinib.
De Stefano L; Bobbio-Pallavicini F; Montecucco C; Bugatti S
Rheumatology (Oxford); 2022 Mar; 61(3):e64-e66. PubMed ID: 34647989
[No Abstract] [Full Text] [Related]
19. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A
Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073
[TBL] [Abstract][Full Text] [Related]
20. Disseminated tinea corporis under baricitinib therapy for atopic dermatitis.
Fiocco Z; Kerl K; French LE; Reinholz M; Dietrich C
Dermatol Ther; 2022 Apr; 35(4):e15351. PubMed ID: 35103361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
